FL2000

FL2000

Étude d'un anticorps monoclonal associé à une thérapie standard (chimiotherapie et interferon-alpha) pour les patients nouvellement diagnostiqués d'un lymphome folliculaire avec une charge tumorale élevée (phase III)

Suivi Long Terme

SLT

Publications 2022

Lysa 2022_LYSA_Validation of POD24 As a Robust Early Clinical Endpoint of Poor Survival in FL from 5,225 Patients on 13 Clinical Trials
Carla Casulo, Jesse G Dixon, Jennifer Le-Rademacher, Eva Hoster, Howard Hochster, Wolfgang Hiddemann, Robert E Marcus, Eva K Kimby, Michael Herold, Catherine J Sebban, Emmanuel Gyan, Kenneth A Foon, Tina G Nielsen, Umberto Vitolo, Gilles Andre Salles, Qian Shi, Christopher R Flowers
Blood . 2022 Mar 17;139(11):1684-1693. En savoir plus
Lysa 2022_LYSA_Genomic and microenvironmental landscape of stage I follicular lymphoma, compared with stage III/IV
G. Tjitske Los-de Vries, Wendy B. C. Stevens, Erik van Dijk, Carole Langois-Jacques, Andrew J. Clear, Phylicia Stathi, Margaretha G. M. Roemer, Matias Mendeville, Nathalie J. Hijmering, Birgitta Sander, Andreas Rosenwald, Maria Calaminici, Eva Hoster Wolfgang Hiddemann, Philippe Gaulard, Gilles Salles, Heike Horn, Wolfram Klapper, Luc Xerri, Catherine Burton, Reuben M. Tooze, Alexandra G. Smith, Christian Buske, David W. Scott, Yasodha Natkunam, Ranjana Advani, Laurie H. Sehn, John Raemaekers, John Gribben, Eva Kimby, Marie Jose Kersten, Delphine Maucort-Boulch, Bauke Ylstra, Daphne de Jong
DOI: 10.1182/bloodadvances.2022008355 En savoir plus

Publications 2021

Lysa 2021_LYSA_Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials
Carla Casulo, Jesse G. Dixon, Fang-Shu Ou, Eva Hoster, Bruce A. Peterson, Howard S. Hochster, Pauline Brice, Marco Ladetto, Wolfgang Hiddemann, Robert Marcus, Eva Kimby, Michael Herold, Tina Nielsen, Franck Morschhauser, Mathias Rummel, Anton Hagenbeek, Umberto Vitolo, Gilles A. Salles, Qian Shi, and Christopher R. Flowers, on behalf of the FLASH group
Blood Adv . 2021 Mar 23;5(6):1737-1745. En savoir plus